phentermine and topiramate · PHENTERMINE HYDROCHLORIDE 11.25 mg/1; TOPIRAMATE 69 mg/1 · Capsule, Extended Release · Oral · Vivus LLC
NDC 62541-0203-30 · 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE · NDA · View full market →
4 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $6.37 per unit over the past year.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | M-308 | Sep 13, 2027 |
| exclusivity | M-308 | Sep 13, 2027 |
| exclusivity | M-308 | Sep 13, 2027 |
| exclusivity | M-308 | Sep 13, 2027 |
| patent | 8580299 | Jun 14, 2029 |
| patent | 8580299 | Jun 14, 2029 |
| patent | 8580299 | Jun 14, 2029 |
| patent | 8580299 | Jun 14, 2029 |
| patent | 8580298 | May 15, 2029 |
| patent | 8580298 | May 15, 2029 |
| patent | 8580298 | May 15, 2029 |
| patent | 8580298 | May 15, 2029 |
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Catalent Pharma Solutions, LLC | PHENTERMINE HYDROCHLORIDE 18.66 mg/1; TOPIRAMATE 92 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Teva Pharmaceuticals, Inc. | PHENTERMINE HYDROCHLORIDE 15 mg/1; TOPIRAMATE 92 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Teva Pharmaceuticals, Inc. | PHENTERMINE HYDROCHLORIDE 11.25 mg/1; TOPIRAMATE 69 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Teva Pharmaceuticals, Inc. | PHENTERMINE HYDROCHLORIDE 3.75 mg/1; TOPIRAMATE 23 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Teva Pharmaceuticals, Inc. | PHENTERMINE HYDROCHLORIDE 7.5 mg/1; TOPIRAMATE 46 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Prasco Laboratories | PHENTERMINE HYDROCHLORIDE 11.25 mg/1; TOPIRAMATE 69 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Prasco Laboratories | PHENTERMINE HYDROCHLORIDE 15 mg/1; TOPIRAMATE 92 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Prasco Laboratories | PHENTERMINE HYDROCHLORIDE 3.75 mg/1; TOPIRAMATE 23 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Prasco Laboratories | PHENTERMINE HYDROCHLORIDE 7.5 mg/1; TOPIRAMATE 46 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Vivus LLC | PHENTERMINE HYDROCHLORIDE 11.25 mg/1; TOPIRAMATE 69 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Vivus LLC | PHENTERMINE HYDROCHLORIDE 3.75 mg/1; TOPIRAMATE 23 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Vivus LLC | PHENTERMINE HYDROCHLORIDE 7.5 mg/1; TOPIRAMATE 46 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Vivus LLC | PHENTERMINE HYDROCHLORIDE 15 mg/1; TOPIRAMATE 92 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Catalent Pharma Solutions, LLC | PHENTERMINE HYDROCHLORIDE 9.33 mg/1; TOPIRAMATE 46 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Catalent Pharma Solutions, LLC | PHENTERMINE HYDROCHLORIDE 14 mg/1; TOPIRAMATE 69 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Catalent Pharma Solutions, LLC | PHENTERMINE HYDROCHLORIDE 4.67 mg/1; TOPIRAMATE 23 mg/1 | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Qsymia — NDC 62541-0203-30," retrieved September 3, 2026, https://drugdashboards.com/drug/62541020330.
Free to cite with attribution — see how the data is put together.